SEPN
Price:
$35.95
Market Cap:
$1.62B
Septerna, Inc. is a biopharmaceutical firm in the clinical development phase, dedicated to the identification and advancement of orally administered, small molecule therapies that modulate G protein-coupled receptors (GPCRs). The company's pipeline is designed to address a spectrum of conditions within endocrinology, immunology and inflammation, and metabolic disorders. Among its key programs, Septerna is developing SEP-786, an oral small molecule serving as a PTH1R agonist for individuals suffering from hypoparathyroidism. Another candidate, SEP-631, is an oral small molecule MRGPRX2 NAM aimed at treating chronic spontaneous urticaria and other mast cell-related ailments. Furthermore, its T...[Read more]
Industry
Biotechnology
IPO Date
2024-10-25
Stock Exchange
NASDAQ
Ticker
SEPN
According to Septerna, Inc.’s latest financial reports and current stock price. The company's current ROE is -9.44%. This represents a change of 294.69% compared to the average of -2.39% of the last 4 quarters.
The mean historical ROE of Septerna, Inc. over the last ten years is -10.20%. The current -9.44% ROE has changed -7.39% with respect to the historical average. Over the past ten years (40 quarters), SEPN's ROE was at its highest in in the June 2024 quarter at 24.26%. The ROE was at its lowest in in the June 2025 quarter at -6.58%.
Average
-10.20%
Median
-11.85%
Minimum
-17.09%
Maximum
0%
Discovering the peaks and valleys of Septerna, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 56.92%
Maximum Annual ROE = 0%
Minimum Annual Increase = -Infinity%
Minimum Annual ROE = -17.09%
| Year | ROE | Change |
|---|---|---|
| 2025 | -12.80% | -25.13% |
| 2024 | -17.09% | 56.92% |
| 2023 | -10.89% | -Infinity% |
The current ROE of Septerna, Inc. (SEPN) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-13.59%
5-year avg
-10.20%
10-year avg
-10.20%
Septerna, Inc.’s ROE is greater than Bicara Therapeutics Inc. Common Stock (-35.89%), greater than Tango Therapeutics, Inc. (-41.54%), greater than Fortrea Holdings Inc. (-79.12%), greater than Prime Medicine, Inc. (-188.82%), greater than Kura Oncology, Inc. (-141.95%), greater than EyePoint Pharmaceuticals, Inc. (-110.54%), less than ProKidney Corp. (7.40%), greater than Maravai LifeSciences Holdings, Inc. (-44.72%), greater than Nurix Therapeutics, Inc. (-64.21%), less than Arbutus Biopharma Corporation (129.32%),
| Company | ROE | Market cap |
|---|---|---|
| -35.89% | $1.19B | |
| -41.54% | $3.85B | |
| -79.12% | $1.56B | |
| -188.82% | $501.21M | |
| -141.95% | $803.41M | |
| -110.54% | $1.09B | |
| 7.40% | $551.46M | |
| -44.72% | $1.38B | |
| -64.21% | $1.47B | |
| 129.32% | $841.51M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Septerna, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Septerna, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Septerna, Inc.'s ROE?
How is the ROE calculated for Septerna, Inc. (SEPN)?
What is the highest ROE for Septerna, Inc. (SEPN)?
What is the 3-year average ROE for Septerna, Inc. (SEPN)?
What is the 5-year average ROE for Septerna, Inc. (SEPN)?
How does the current ROE for Septerna, Inc. (SEPN) compare to its historical average?